Biomarkers for hepatocellular cancer |
| |
Authors: | Gurjot Singh Eric M Yoshida Sahaj Rathi Vladimir Marquez Peter Kim Siegfried R Erb Baljinder S Salh |
| |
Institution: | Gurjot Singh, Department of Medicine, University of British Columbia, Vancouver V5Z 1M9, CanadaEric M Yoshida, Sahaj Rathi, Vladimir Marquez, Siegfried R Erb, Baljinder S Salh, Division of Gastroenterology, Department of Medicine, University of British Columbia, Vancouver V5Z 1M9, CanadaPeter Kim, Division of Oncological Surgery, Department of Medicine, University of British Columbia, Vancouver V5Z 1M9, Canada |
| |
Abstract: | Hepatocellular carcinoma(HCC) is the third leading cause of cancer-related deaths worldwide. If diagnosed early, curative treatment options such as surgical resection, loco-regional therapies, and liver transplantation are available to patients, increasing their chances of survival and improving their quality of life. Unfortunately, most patients are diagnosed with late stage HCC where only palliative treatment is available. Therefore, biomarkers which could detect HCC early with a high degree of sensitivity and specificity, may play a crucial role in the diagnosis and management of the disease. This review will aim to provide an overview of the different biomarkers of HCC comprising those used in the diagnosis of HCC in at risk populations, as well as others with potential for prognosis, risk predisposition and prediction of response to therapeutic intervention. |
| |
Keywords: | Biomarkers Hepatocellular carcinoma Liver cancer Cancer Review Serum Plasma Scoring models Algorithm Genetic Micro-RNA miRNA Diagnosis Prognosis Liquid biopsy |
本文献已被 CNKI 等数据库收录! |
| 点击此处可从《World journal of hepatology》浏览原始摘要信息 |
|